NEURONA THERAPEUTICS, INC

Profile

Company Names

NEURONA THERAPEUTICS, INC
NEURONA THERAPEUTICS INC

Addresses

170 HARBOR WAY, SOUTH SAN FRANCISCO, CA 94080

650 GATEWAY BOULEVARD, SUITE 125, SOUTH SAN FRANCISCO, CA 94809

1700 OWENS ST., SUITE 500, SAN FRANCISCO, CA 94158

Phone Numbers

650-799-6465

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$347,475,339.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2025-03-28 
$101,711,423.00 
$101,711,423.00 
$0.00 
Equity 
5
2024-02-06 
$119,999,974.00 
$119,999,974.00 
$0.00 
Equity 
4
2021-03-19 
$72,008,582.00 
$91,598,577.00 
$19,589,995.00 
Equity 
3
2019-11-18 
$15,030,288.00 
$49,999,999.00 
$34,969,711.00 
Equity 
2
2018-02-08 
$10,044,329.00 
$20,044,332.00 
$10,000,003.00 
Equity 
1
2014-12-09 
$28,680,743.00 
$30,300,001.00 
$1,619,258.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
GOEDDEL 
DIRECTOR
IGENICA INC   |  NGM BIOPHARMACEUTICALS INC   |  CONSTELLATION PHARMACEUTICALS INC   |  PELOTON THERAPEUTICS, INC.   |  NURIX, INC.   |  NEURONA THERAPEUTICS INC   |  IGENICA BIOTHERAPEUTICS, INC   |  FLX BIO, INC.   |  EXONICS THERAPEUTICS, INC.   |  SURROZEN, INC.   |  A2 BIOTHERAPEUTICS, INC.   |  HEXAGON BIO INC.   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  NGM BIO HOLDINGS, INC.
LEO 
 
GUTHART 
DIRECTOR
MIRIMUS, INC.   |  SECURITY FIRST CORP.   |  PASSPORT SYSTEMS INC   |  TOPSPIN PARTNERS II, LP   |  TOPSPIN PARTNERS II OFFSHORE, LP   |  TOPSPIN ASSOCIATES II, LP   |  NEURONA THERAPEUTICS INC   |  NEURONA THERAPEUTICS, INC   |  DEPYMED INC.   |  SION POWER CORP
STEPHEN 
 
HAUSER 
DIRECTOR
NEURONA THERAPEUTICS INC   |  NEURONA THERAPEUTICS, INC
RAY 
 
KELLEHER 
DIRECTOR
NEURONA THERAPEUTICS, INC
ARNOLD 
 
KRIEGSTEIN 
DIRECTOR
NEURONA THERAPEUTICS INC   |  NEURONA THERAPEUTICS, INC
ARNOLD 
R. 
KRIEGSTEIN 
DIRECTOR
NEURONA THERAPEUTICS INC
TIM 
 
KUTZKEY 
DIRECTOR, EXECUTIVE OFFICER
CARMOT THERAPEUTICS INC.   |  CYTERIX PHARMACEUTICALS INC.   |  PELOTON THERAPEUTICS, INC.   |  NEURONA THERAPEUTICS INC   |  KALLYOPE, INC.   |  COLUMN GROUP III-A, LP   |  COLUMN GROUP III, LP   |  SURROZEN, INC.   |  NEURONA THERAPEUTICS, INC   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  COLUMN GROUP-NEURO II, LP   |  SITE TX, INC.   |  NILO THERAPEUTICS, INC.   |  NGM BIO HOLDINGS, INC.
BRAD 
 
MARGUS 
DIRECTOR
ARVINAS HOLDING COMPANY, LLC   |  NEURONA THERAPEUTICS, INC   |  HC BIOSCIENCE, INC.
CORY 
 
NICHOLAS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
NEURONA THERAPEUTICS INC   |  NEURONA THERAPEUTICS, INC
JAMES 
 
STUTZ 
EXECUTIVE OFFICER
TIOMA THERAPEUTICS, INC.   |  TOLERION, INC.   |  NEURONA THERAPEUTICS, INC
PETER 
 
SVENNILSON 
DIRECTOR
FARALLON BIOSCIENCES, INC   |  NGM BIOPHARMACEUTICALS INC   |  COLUMN GROUP II, LP   |  ARAGON PHARMACEUTICALS, INC.   |  PTC THERAPEUTICS, INC.   |  IMMUNE DESIGN CORP.   |  COLUMN GROUP II, LP   |  COLUMN GROUP III-A, LP   |  COLUMN GROUP III, LP   |  CONSTELLATION PHARMACEUTICALS INC   |  CIRCLE PHARMA, INC.   |  CARMOT THERAPEUTICS INC.   |  COLUMN GROUP-NEURO, LP   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  COLUMN GROUP-NEURO II, LP   |  NGM BIO HOLDINGS, INC.   |  NEURONA THERAPEUTICS, INC
ROBERT 
 
TIJAN 
DIRECTOR
NEURONA THERAPEUTICS INC
ROBERT 
 
TJIAN 
DIRECTOR
ESCIENT PHARMACEUTICALS INC   |  NEURONA THERAPEUTICS INC   |  NURIX THERAPEUTICS, INC.   |  NEURONA THERAPEUTICS, INC
ERICA 
 
WHITAKER 
DIRECTOR
NEURONA THERAPEUTICS, INC
ERICA 
 
WHITTAKER 
DIRECTOR
ALLY THERAPEUTICS, INC.   |  NEURONA THERAPEUTICS, INC   |  STRIDEBIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-04-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-03-28 
2024-02-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-06 
2022-12-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-19 
2021-03-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-19 
2019-11-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-18 
2018-02-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-08 
2016-12-28
D/A
Link
BIOTECHNOLOGY 
 
NOT APPLICABLE 
Equity 
2014-12-09 
2014-12-23
D
Link
BIOTECHNOLOGY 
 
NOT APPLICABLE 
Equity 
2014-12-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#